Connect with us
AstraZeneca will make a first payment of $200 million and another of $120 million in consideration, for Neogene Therapeutics. AstraZeneca is building a portfolio of cell...
Peaches Biotech is a company specializing in the creation of medicines based on advanced therapies, especially with cytokines, stem cells, or T-lymphocytes, which will allow patients...
Exheus analyzes the expression of all the genes in the human body present in the blood transcriptome to detect and correct anomalies that affect a person's...
Santana will be responsible, among other tasks, for Doctomatic's deployment in Latin America, which the company expects to be completed within the next year after having...
Merck MSD acquired Imago BioSciences and expects the deal to close in the first quarter of 2023. Novo Nordisk will invest €726 million (DKK 5.4 billion)...
If this round is successfully completed, Mediquo would add its sixth operation of this size. In April 2021, Encomenda Smart Capital and Dozen Investments led a...
The new healthcare information and data environment that Europe intends to develop "will be the driving force behind healthcare research, the development of digital technologies and...
Following these results, Almirall has confirmed its financial estimates for 2022. Investment in research and development (R&D) increased by 11.3% in the period, to €71.6 million...
Arthex Biotech is a spin-off of the University of Valencia (UV). Incorporated in September 2019, the company has its focus on the development of a treatment...
The service, also known as AlphaID At Home, is Grifols' first FDA-cleared service for direct-to-consumer use. It will be available beginning in the second quarter of...